Hereditary Cancer Testing Market Scope And Analysis

Report Code : TIPRE00006578
Category : Life Sciences

No. of Pages : 150

Buy Now

Hereditary Cancer Testing Market Scope and Analysis Report by 2031

Buy Now

Hereditary Cancer Testing Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 5.05 Billion
Market Size by 2031	US$ 14.59 Billion
Global CAGR (2023 - 2031)	11.3%
Historical Data	2021-2022
Forecast period	2023-2031
Segments Covered	By Diagnosis Type Biopsy Imaging By Technology Sequencing PCR Microarray By End User Hospital Clinics Diagnostic Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Hologic Inc Koninklijke Philips N V Quest Diagnostics Incorporated Myriad Genetics Inc Cancer Genetics Inc Invitae Corporation Myogenes Strand Life Sciences Pvt Ltd Pathway Genomics Corporation CENTOGENE AG

Hereditary Cancer Testing Market News and Recent Developments

The hereditary cancer testing market is evaluated by gathering qualitative and quantitative data from primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for hereditary cancer testing:

Exact Sciences Corp. announced the Riskguard hereditary cancer test launch in the United States. This test provides an individualized patient report that includes gene-specific and familial risks using a simple blood or saliva sample for 10 common cancers, including colorectal, endometrial, gastric, pancreatic, breast, prostate, skin, ovarian, kidney and endocrine. (Exact Sciences Corp /Press Release, February 2024)
Devyser announced the launch of two new products, Devyser LynchFAP and Devyser BRCA PALB2. These kits offer efficient, targeted, and confident analysis of genes associated with increased cancer risk. Devyser LynchFAP provides a comprehensive solution to analyze PMS2 and 9 other genes associated with hereditary colorectal cancer syndromes (Source: Devyser, Press Release, June 2023)

Hereditary Cancer Testing Market Report Coverage and Deliverables

The “Hereditary Cancer Testing Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles